Joana Goncalves, Chief Medical Officer at Oruka Therapeutics, Inc. (ORKA), sold 7,000 shares at $61.56 ($433K) on 2026-05-15, disclosed to the SEC on 2026-05-15.
Scheduled sale ($433k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.56 | 4,800 | $295K | 68.3% |
| 2 | $62.42 | 2,100 | $131K | 30.3% |
| 3 | $63.52 | 100 | $6K | 1.5% |
| Total | $61.85 avg | 7,000 | $433K | 100% |
| Filing → |
| ORKA | SELL | 2026-08-17 | $783K | — | Filing → |
| ORKA | SELL | 2026-07-15 | $604K | — | Filing → |
| ORKA | SELL | 2026-06-15 | $551K | — | Filing → |